InnoCare Pharma Limited
INCPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $958 | $7,056 | $7,008 | $6,223 |
| Short-Term Investments | $28 | $40 | $0 | $1,063 |
| Receivables | $65 | $392 | $364 | $371 |
| Inventory | $18 | $118 | $97 | $96 |
| Other Curr. Assets | $50 | $6,321 | $429 | $68 |
| Total Curr. Assets | $1,118 | $7,845 | $7,897 | $7,820 |
| Property Plant & Equip (Net) | $106 | $775 | $797 | $814 |
| Goodwill | $0 | $3 | $3 | $3 |
| Intangibles | $35 | $253 | $256 | $36 |
| Long-Term Investments | $4 | $59 | $0 | -$603 |
| Tax Assets | $0 | $0 | $0 | $603 |
| Other NC Assets | $74 | $428 | $460 | $734 |
| Total NC Assets | $219 | $1,519 | $1,516 | $1,587 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,337 | $9,364 | $9,414 | $9,407 |
| Liabilities | – | – | – | – |
| Payables | $21 | $178 | $166 | $128 |
| Short-Term Debt | $46 | $174 | $176 | $225 |
| Tax Payable | $0 | $0 | $0 | $31 |
| Deferred Revenue | $5 | $0 | $0 | $0 |
| Other Curr. Liab. | $99 | $672 | $666 | $676 |
| Total Curr. Liab. | $171 | $1,024 | $1,007 | $1,061 |
| LT Debt | $188 | $1,364 | $1,369 | $1,046 |
| Deferred Rev, NC | $40 | $0 | $0 | $251 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $257 | $271 | $303 |
| Total NC Liab. | $229 | $1,621 | $1,640 | $1,601 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $48 | $25 | $59 |
| Total Liabilities | $399 | $2,645 | $2,648 | $2,662 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$784 | -$5,550 | -$5,502 | -$5,495 |
| AOCI | $1,721 | $118 | $12,260 | $0 |
| Other Equity | -$1 | $12,135 | -$9 | $12,220 |
| Total Equity | $936 | $6,703 | $6,749 | $6,725 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $2 | $15 | $17 | $21 |
| Total Liab. & Tot. Equity | $1,337 | $9,364 | $9,414 | $9,407 |
| Net Debt | -$724 | -$5,518 | -$5,463 | -$4,951 |